Top 5 Pharma Looks to LifeSphere IDMP for Regulatory Readiness
ArisGlobal’s industry-leading regulatory software chosen by top pharmaceutical company for IDMP preparation and global readiness MIAMI, Feb 15 – ArisGlobal, the leading provider of life sciences...
View ArticleChecklist: Essential Features of a Future-Proof Automated eTMF System
The post Checklist: Essential Features of a Future-Proof Automated eTMF System appeared first on ArisGlobal.
View ArticleLeveraging IDMP Across All Business Functions to Proactively Manage Global...
The post Leveraging IDMP Across All Business Functions to Proactively Manage Global Regulatory Affairs appeared first on ArisGlobal.
View ArticleElectronic Trial Master File (eTMF) Checklist: Discover the Value Your eTMF...
A well-prepared Trial Master File (TMF) is critical to the success of any clinical trial. Because the TMF tells the whole story of a study – including every data point collected and decision made –...
View ArticleTo Prepare for IDMP, Organizations Must Think Years Ahead – Not Months
When selecting an IDMP solution, remember decisions made today will impact the organization for years to come After a decade of preparation, the new Identification of Medicinal Products (IDMP) standard...
View ArticleArisGlobal Recognized in 2021 Gartner® Hype Cycle™
Leading automated drug development technology platform LifeSphere recognized for outstanding Life Science Research and Development capabilities MIAMI (March 9, 2022) — ArisGlobal, the leading provider...
View ArticleArisGlobal’s LifeSphere Safety Solidifies Market Leading Position in...
ArisGlobal’s signature R&D Safety suite continues to record substantial global gains within the life sciences industry, including 30 of the Top 50 global pharma organizations. MIAMI, FL –...
View ArticleSynergy and Efficiencies Within: The Benefits of a Connected Clinical Platform
Change is the lone constant you can depend on. When it comes to scientific discovery, most of that change – whether it be in smart phones or space travel – has led to greater achievements and...
View ArticleLifeSphere Medical Affairs Product Leader to Present at DIA MASC
MIAMI, FL – March 18, 2022 – ArisGlobal®, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere®, today...
View ArticleBenefits of Integrating Your Medical Information and Safety Workflows
Data is the lifeblood of businesses today. Data informs strategy and measures success across all industries. While some companies now understand its potential, most are still determining how best to...
View ArticleArisGlobal to Attend and Speak on Regulatory Data at GPRAS in Berlin
In person attendance, speaking session, and LifeSphere Regulatory demos mark the life sciences software leader’s return to the convention circuit. MIAMI, April 1 – ArisGlobal®, the leading provider of...
View ArticleArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins...
ArisGlobal’s LifeSphere sees significant uptake of clinical software adoption in key clinical trial markets worldwide. MIAMI, FL – ArisGlobal, the leading provider of life sciences software that...
View ArticleNot Your Average RIMS: Managing Increasing Complexity in Regulatory Affairs
Managing the submission of medicinal products, medical devices, and biologics to regulatory agencies is growing more complicated all the time. To streamline the processes that go into creating and...
View ArticleArisGlobal Brings LifeSphere Clinical Leadership to Discuss Remote and Onsite...
LifeSphere Clinical continues to make a substantial industry impact providing actionable thought leadership at clinical events nationwide. NEW ORLEANS, May 2 – ArisGlobal®, the leading provider of life...
View ArticleArisGlobal Continues Growth with Key Leadership Hires and Expanded Functions
Life sciences technology leader welcomes five executives to elevate the organization across the business, information security, and compliance sectors. MIAMI, FL — April 26— ArisGlobal, the leading...
View ArticleArisGlobal Acquires Boehringer Ingelheim’s Signal Analytics Engine, Bringing...
● ArisGlobal announces acquisition of Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated...
View ArticleThe Risks and Rewards of Decentralized Clinical Trials
DCTs completely revise historical trial processes by executing trials through telemedicine and mobile or local health care providers. Although COVID increased the need for DCTs, 75% of the industry...
View ArticleCOVID-19 and Vaccine Safety Brings Pharmacovigilance Center Stage
The public is more aware of drug safety and health regulators’ role than ever — and as the demand for pharmacovigilance (PV) information rises, the industry has had to find ways to keep up. Read more...
View ArticleStaying Ahead of ICH E6(R3) Good Clinical Practice Guidelines
Modernization is critical to enhance patient experience and boost clinical trial productivity. Read more from Dario Lirio, Senior Director, LifeSphere Clinical on Quality Digest. The post Staying Ahead...
View ArticleBreakthroughs in Safety Analytics – Discovering the Undiscoverable in...
The post Breakthroughs in Safety Analytics – Discovering the Undiscoverable in Pharmacovigilance appeared first on ArisGlobal.
View Article